Johnson & Johnson number of employees

Johnson & Johnson reported 138,200 employees at December 28, 2025 in its latest annual report, up 100 (0.1%) on the year before. That compares with 141,700 at January 2, 2022. Revenue per employee was $681,570.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
December 28, 2025	138,200	+100 (0.1%)	$681,570	10-K, filed February 11, 2026
December 29, 2024	138,100	+6,200 (4.7%)	$643,164	10-K, filed February 13, 2025
December 31, 2023	131,900	−20,800 (13.6%)	$645,633	10-K, filed February 16, 2024
January 1, 2023	152,700	+11,000 (7.8%)	$523,838	10-K, filed February 16, 2023
January 2, 2022	141,700	—	$555,681	10-K, filed February 17, 2022

What the annual reports say

Business General Johnson & Johnson and its subsidiaries (the Company) have approximately 138,200 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. 2025 annual report
Business General Johnson & Johnson and its subsidiaries (the Company) have approximately 138,100 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. 2024 annual report
Business General Johnson & Johnson and its subsidiaries (the Company) have approximately 131,900 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. 2023 annual report
BUSINESS General Johnson & Johnson and its subsidiaries (the Company) have approximately 152,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. 2023 annual report
BUSINESS General Johnson & Johnson and its subsidiaries (the Company) have approximately 141,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. 2022 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: JNJ vs LLY JNJ vs PFE

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Johnson & Johnson's SEC filings (10-K and 10-Q), retrieved October 23, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Johnson & Johnson.